Wits Launches First Covid-19 Vaccine Trial In SA

Advertisement
 

Wits has started the first vaccine trial for Covid-19 in South Africa. Wits University is collaborating with the University of Oxford and the Oxford Jenner Institute on the vaccine trial.

The University of the Witwatersrand (Wits) has launched the first vaccine trial for Covid-19 in South Africa. They have come together with the University of Oxford and the Oxford Jenner Institute to make this possible. The first participants will be vaccinated this week.

The announcement for this vaccine trial came on 23 June at a virtual press conference by Wits and is expected to be a major step forward in the Covid-19 global pandemic. 

The technical name of the vaccine is ChAdOx1 nCoV-19, as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus. 

Wits has stated, "The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19." 

The vaccine was found to be safe. “This is a landmark moment for South Africa and Africa at this stage of the Covid-19 pandemic. As we enter winter in South Africa and pressure increases on public hospitals, now more than ever we need a vaccine to prevent infection by Covid-19,” said Shabir Madhi, Professor of Vaccinology at Wits University.

The vaccine was initially developed by scientists at Oxford University. It is estimated that a billion doses will be able to be manufactured per year, should the vaccine work. 

Professor Zeblon Vilakazi, Vice Principal and Deputy Vice Chancellor: Research and Postgraduate Affairs at the Wits University, has said that, "Vaccines are amongst the most powerful tools to mitigate life-threatening diseases. Without a vaccine against Covid-19, there will likely be ongoing contagion, causing severe illness and death."

Vaccine trials are also being run in the UK and similar studies are about to start in Brazil. An even larger study of the same vaccine of up to 30,000 participants is planned in the USA.

There are currently over 100 candidate Covid vaccines in development around the world.

Read Wits' full statement here


Advertisement

 


Advertisement


Other Articles

Are you not sure which career direction you should take after matric? We asked the experts for some advice.

Some R350 grant beneficiaries might have had their application been rejected which lead them to appeal. It might occur that the appeal upholds the rejection status. Can something be done about this?

Advertisement


Latest SASSA Articles

Some R350 grant beneficiaries might have had their application been rejected which lead them to appeal. It might occur that the appeal upholds the rejection status. Can something be done about this?

Many applicants of the R350 Social Relief of Distress (SRD) grant have had their applications rejected for various reasons, but the question is what will happen if they don't appeal this status? Here is what the Independent Appeals Tribunal said on the matter. 


Advertisement


Careers Advice

As students and their parents look ahead to 2023, it is both an exciting and nerve-wracking time. Will you be able to study or work towards a qualification? What are the options? If you can, how much will it cost, and can you afford it? 

Learnerships are work-based learning programmes consisting of both theory and practical elements that give you an opportunity to gain work experience. If you are interested in joining in the police force, you might want to consider applying for the South African Police Services (SAPS) learnership programme.

Advertisement